Literature DB >> 395061

Growth hormone reserve capacity in Turner's syndrome.

F Laczi, J Julesz, T Janáky, F A László.   

Abstract

In 11 untreated and 6 oestrogen-treated Turner's syndrome patients, the changes in the serum growth hormone level were studied following the induction of hypoglycaemia with insulin. The growth hormone was measured with a radioimmune assay technique. The growth hormone peak value measured in healthy females was 54.32 +/- 17.17, in untreated Turner's syndrome was 14.90 +/- 3.71, and in oestrogen-treated Turner patients was 33.38 +/- 9.22 microU/ml (average +/- standard error). On the basis of the results, a role is attributed to the decreased growth hormone reserve in the low growth of Tuner's syndrome patients.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 395061     DOI: 10.1055/s-0028-1092795

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  4 in total

1.  Methionyl human growth hormone in Turner's syndrome.

Authors:  C Rongen-Westerlaken; J M Wit; S L Drop; B J Otten; W Oostdijk; H A Waal; M H Gons; A Bot; J L Van den Brande
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

2.  Growth hormone treatment in Turner syndrome accelerates growth and skeletal maturation. Dutch Growth Hormone Working Group.

Authors:  C Rongen-Westerlaken; J M Wit; S M De Muinck Keizer-Schrama; B J Otten; W Oostdijk; H A Delemarre-van der Waal; M H Gons; A Bot; J L Van den Brande
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

3.  Growth hormone treatment of Turner syndrome patients with insufficient growth hormone response to pharmacological stimulation tests.

Authors:  G Massa; M Vanderschueren-Lodeweyckx; M Craen; M Vandeweghe; G van Vliet
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183

4.  Growth hormone secretion in Turner's syndrome and influence of oxandrolone and ethinyl oestradiol.

Authors:  A A Massarano; C G Brook; P C Hindmarsh; P J Pringle; J D Teale; R Stanhope; M A Preece
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.